Verastem, Inc. (VSTM): Price and Financial Metrics
VSTM Price/Volume Stats
| Current price | $6.73 | 52-week high | $13.52 |
| Prev. close | $6.40 | 52-week low | $2.10 |
| Day low | $6.28 | Volume | 815,890 |
| Day high | $6.89 | Avg. volume | 1,067,990 |
| 50-day MA | $6.11 | Dividend yield | N/A |
| 200-day MA | $4.13 | Market Cap | 346.51M |
VSTM Stock Price Chart Interactive Chart >
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Price Returns
| 1-mo | 23.49% |
| 3-mo | 81.40% |
| 6-mo | 150.19% |
| 1-year | -43.06% |
| 3-year | -57.51% |
| 5-year | -77.74% |
| YTD | 30.17% |
| 2024 | -36.49% |
| 2023 | 68.53% |
| 2022 | -80.37% |
| 2021 | -3.76% |
| 2020 | 58.96% |
Continue Researching VSTM
Here are a few links from around the web to help you further your research on Verastem Inc's stock as an investment opportunity:Verastem Inc (VSTM) Stock Price | Nasdaq
Verastem Inc (VSTM) Stock Quote, History and News - Yahoo Finance
Verastem Inc (VSTM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...